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In this work, we biochemically characterized inositol phosphosphingolipid-phospholipase C (Isc1)
from the pathogenic fungus Cryptococcus neoformans. Unlike Isc1 from other fungi and parasites
which hydrolyze both fungal complex sphingolipids (IPC-PLC) and mammalian sphingomyelin
(SM-PLC), C. neoformans Isc1 only exerts IPC-PLC activity. Genetic mutations thought to regulate
substrate recognition in other Isc1 proteins do not restore SM-PLC activity of the cryptococcal
enzyme. C. neoformans Isc1 regulates the level of complex sphingolipids and certain species of phy-
toceramide, especially when fungal cells are exposed to acidic stress. Since growth in acidic environ-
ments is required for C. neoformans to cause disease, this study has important implications for
understanding of C. neoformans pathogenicity.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In the past several years, it has become increasingly clear that
sphingolipid metabolism is intimately linked with the virulence
of the fungal pathogen Cryptococcus neoformans (Cn), a medically
important microorganism [1]. Cn is a facultative intracellular path-
ogen and it can grow and replicate within the phagolysosome of
phagocytic cells, such as alveolar macrophages (AMs), as well as
in the extracellular spaces, such as in the alveoli or in the blood-
stream [2–6].
Our laboratory has previously showed that cryptococcal sphin-
golipids regulates signaling events leading to the production of vir-
ulence factors [7,8] and to the regulation of phagocytosis [9,10].
Interestingly, sphingolipid not only regulate the internalization of
Cn by macrophages but also promote fungal growth in these envi-
ronments (intracellular and extracellular). Intracellular fungal
growth is controlled by Ipc1 [11] and inositol phosphosphingoli-chemical Societies. Published by E
istry and Molecular Biology,
nue, BSB 503, Charleston, SC
).pid-phospholipase C 1 (Isc1) [12], whereas extracellular growth
is controlled by glucosylceramide synthase (Gcs1) [13,14] (Fig. 1).
The regulation of these processes signiﬁcantly affects the interac-
tion of Cn with macrophages, particularly in the lung environment
with an important effect on the outcome of the disease.
In Saccharomyces cerevisiae (Sc) the enzyme which hydrolyzes
complex sphingolipids, such as inositol phosphorylceramide
(IPC), generating phytoceramide and inositol phosphate was iden-
tiﬁed as Isc1 by Sawai et al. [15]. In vitro, Sc Isc1 metabolizes not
only IPC and its mannosylated derivatives mannosylinositol
phosphorylceramide (MIPC) and mannosyldiinositol phosphoryl-
ceramide (M(IP)2C), thus exerting IPC-PLC activity, but it also
metabolizes the mammalian complex sphingolipid sphingomyelin
(SM), thus exerting SM-PLC activity, in spite of the fact that fungal
cells do not contain SM [15].
In the parasite Leishmania major, the Isc1 homolog (ISCL) does
possess both IPC-PLC and SM-PLC activity, even though the para-
site does not produce SM and, the breakdown of host SM is an
essential process for L. major to cause disease [16].
In Cn, deletion of Isc1 generated a Cn mutant (Disc1) that is
hypersensitive in vitro to nitrogen oxide, hydrogen peroxide and
acidic stresses and, thus, it cannot survive within the phagolyso-
some of macrophages. In this study, we examined the biochemicallsevier B.V. All rights reserved.
Fig. 1. Ipc1 and Isc1 biosynthetic pathway. Ipc1 consumes phytoceramide and generates diacylglycerol (DAG) in the synthesis of IPC, which is subsequently transformed into
MIPC and M(IP)2C. Isc1 generates phytoceramide in the hydrolysis of IPC, MIPC or M(IP)2C. The mammalian homologs, sphingomyelin synthase (SMS1 and SMS2) and
sphingomyelinase (SMases), which consume and generate ceramide, respectively, are shown for comparison. In fungal cells, the fatty acid in the phytoceramide species can
be hydroxylated (in gray) in position 2 (dotted line). Bracket’s numbers represent the length of the sphingosine backbone and fatty acids. PI, Phosphatidylinositol; DAG,
diacylglycerol; PC, phosphatidylcholine.
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features of the Cn strain lacking Isc1 compared to the wild type
(WT) and a reconstituted strain (Disc1REC) in acidic and neutral
conditions.2. Materials and methods
2.1. Strains and growth media
Cn var. grubii serotype A strain H99 wild type (WT); Cn var.
neoformans serotype D strain JEC21; Cn var. gattii serotype B (strain
MMRL 1336) and serotype C (strain MMRL 1343) [the latter two
strains were a kind gift fromWiley Schell, Duke University Medical
Center, Durham, NC, USA]; Candida albicans (Ca) wild type strain
A39; Schizosaccharomyces pombe strains 972 (h) and 975 (h+);
S. cerevisiae wild type strain (Jk9-3Da); Sc Disc1 strain [15]; Cn
Isc1 deletion strain (Cn Disc1) and the reconstituted strain
(Disc1REC) were used in this study. For in vitro growing condition,
please see Supplementary materials.2.2. In vitro IPC and sphingomyelin SM phospholipase C (IPC-PLC and
SM-PLC) activity
Phospholipase C activity against IPC (IPC-PLC) was performed as
previously described [15]. Brieﬂy, cell lysates containing 100 lg
protein were incubated at 30 C for 30 min in 100 ll of buffer con-
taining 50 mM Tris (pH 7.5), 5 mM MgCl2, 5 mM dithiothreitol,
0.1% Triton X-100, 10 nmol of phosphatidylserine (Avanti Polar
Lipids), 2 nmol of unlabeled IPC, and 30 000 dpm ofmyo-[2-3H]ino-
sitol-labeled IPC. After the incubation, 0.8 ml of chloroform, 0.4 ml
of methanol, and 0.2 ml of 1% perchloric acid were added [17], and
the radioactivity in a portion (300 ll) of the upper (aqueous) phase
was measured by liquid scintillation counting. Phospholipase C
activity against SM (SM-PLC) was tested in a similar manner, ex-
cept that 2 nmol SM and 30 000 dpm of [choline-methyl-14C]-
labeled SMwere used in place of unlabeled and labeled IPC, respec-
tively. After incubation, 0.8 ml of chloroform, 0.4 ml of methanol,
and 0.2 ml of distilled water were added and the radioactivity in
a portion (300 ll) of the upper phase was measured by liquid scin-
tillation counting. As a negative control, the Sc Disc1 + pYES empty
Fig. 2. Cryptococcus neoformans (Cn) and C. albicans (Ca) lack SM-PLC Activity. Crude
cell lysates from fungi were assessed for neutral phospholipase C (PLC) activity
against either inositol phosphorylceramide (IPC) or sphingomyelin (SM). The fungi
tested included Sc (Sc), Cn var. grubii serotype A strain H99 (Cn A), Cn var. gattii
serotype B (Cn B), Cn var. gattii serotype C (Cn C), Cn var. neoformans serotype D (Cn
D), Ca, and S. pombe (Sp).
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values obtained with Isc1 wild-type or mutated forms. Experi-
ments were repeated at least three times. Radiolabeled IPC was
prepared by incubating WT cultures with [2-3H] inositol for 4 h
and extracting sphingolipids as previously described. Non-radioac-
tive labeled C26-IPC was custom-made by Avanti Polar Lipids, Ala-
baster, AL, USA.
2.3. Mutagenesis studies
The Cn Isc1 cDNA from wild-type of mutated forms were sub-
cloned from pCR-TOPO-Cn-Isc1 [12] into the pYES vector (Invitro-
gen) and the Xpress tag was inserted at the 50 of the Cn Isc1 gene to
monitor protein expression in Sc Disc1 cells. Mutagenesis studies
were performed as described in the Supplementary materials and
the primers used are illustrated in the Supplementary Table 1.
For molecular docking studies, coordinates for phosphocholine
were generated and docked manually into the Bc Isc1 structure
using the program O version 11 [18].
2.4. In vivo labeling with 3H-inositol or 3H dihydrosphingosine
For quantitative measurements of IPC-B, IPC-C/D, MIPC and
M(IP)2C in Cn wild-type, Disc1 and Disc1REC strain, cells were incu-
bated for 30 min with 25 lCi of myo-[2-3H] inositol (20 Ci/mmol),
and the lipid were extracted and loaded onto a TLC on silica gel 60
plates (EM Science) using the solvent system chloroform/metha-
nol/water (65:25:4). The separated radioactive lipids were scraped
from the TLC and quantiﬁed using a liquid scintillation counter
[15]. The mass of each species was normalized to phosphorus lev-
els of each sample. Further details are illustrated in the Supple-
mentary materials.
2.5. Extraction and mass spectrometry analysis of yeast sphingolipids
Lipids for mass spectrometry analysis were extracted by stan-
dard methods (please see Supplementary materials). An aliquot
of the extraction (300 ll) was used for phosphorous determination.
Internal standards were added to the remaining aliquots, and
sphingolipids were extracted in a one-phase neutral organic sol-
vent (propan-2-ol/water/ethyl acetate, 30:10:60, by vol.). Samples
were then analyzed by a Surveyor/TSQ 7000 liquid chromatogra-
phy–MS system.
2.6. Statistical analysis
The two-way analysis of variance (ANOVA) was used. For all
statistical tests, P-values less than 0.05 were considered signiﬁcant.Fig. 3. Expression of C. neoformans (Cn) Isc1 in S. cerevisiae (Sc) Disc1 does not
restore SM-PLC activity. (A) IPC-PLC and SM-PLC activity using protein lysates
obtained from Sc Disc1 + pYES Sc Isc1 mixed with 50, 100 or 150 lg of Cn protein
lysates. (B) IPC-PLC and (C) SM-PLC activity of Sc wild-type (WT) + pYES empty, Sc
Disc1 + pYES empty, Sc Disc1 + pYES Sc Isc1, and Sc Disc1 + pYES Cn (Cn) Isc1. Data
are average ± standard deviation of three separate experiments.3. Results and discussion
3.1. Cn lacks sphingomyelinase activity
Our ﬁrst interest was to investigate whether Cn cell protein ly-
sates would hydrolyze the mammalian complex sphingolipid
sphingomyelin (SM), as was observed for the Sc protein lysates.
Unexpectedly, we found that Cn cannot metabolize SM (Fig. 2),
suggesting that the cryptococcal Isc1 does not have SM-PLC activ-
ity. In addition, we did not detect any SM-PLC activity in other ser-
otypes (B, C and D) of Cn, nor in another pathogenic yeast, such as
C. albicans (Ca). As expected, we did detect SM-PLC activity in Sc
and in Saccharomyces pombe protein lysates. We conﬁrmed these
results by in vivo labeling with NBD-labeled C6-SM, and found
that, whereas Sc could generate NBD-labeled ceramide, Cn could
not (data not shown). These results suggest that the cryptococcalIsc1 enzyme may possess different biochemical properties than
those exerted by Sc.
Because we observed that Cn protein extracts do not possess
SM-PLC activity (Fig. 2), we wondered whether a cryptococcal fac-
tor(s) may inhibit such activity. To address this hypothesis, differ-
ent concentrations of protein lysates isolated from CnDisc1mutant
were mixed with protein lysates isolated from Sc Disc1 + pYES Sc
Isc1, and IPC-PLC and SM-PLC activities were measured. We found
that presence of Cn proteins did not inhibit SM-PLC or IPC-PLC
activities of Sc Isc1 (Fig. 3A). Next, we wondered whether a fac-
tor(s) from Sc would be necessary for SM-PLC activity. Thus, the
Cn Isc1 cDNA was expressed into the Sc Disc1 strain and both
IPC- and SM-PLC activity were measured. Sc Isc1 cloned into pYES
was used as a positive control, whereas the pYES empty plasmid
was used as a negative control. As additional controls for Isc1
protein expression, we also included the Sc wild-type JK-3Da
638 J. Henry et al. / FEBS Letters 585 (2011) 635–640transformed with pYES empty vector. We found that IPC-PLC activ-
ity is promptly restored in the Sc Disc1 strain when over-express-
ing either Sc Isc1 or Cn Isc1 (Fig. 3B). However, only the expression
of Sc Isc1 and not Cn Isc1 restores SM-PLC activity in the Sc Disc1
strain (Fig. 3C). These results suggest that Cn Isc1 is biochemically
different from Sc Isc1 in terms of substrate speciﬁcity.
3.2. Functional analysis of Cn Isc1 by site-directed mutagenesis of the
P-loop-like domain
Studies on the Sc Isc1 [19,20] and Bacillus cereus SMase [21]
have identiﬁed distinct domains within the enzyme which are
essential for substrate binding and hydrolysis. One such domain,
the P-loop-like domain, shows homology among the Isc1 super-
family, including bacterial and human SMases. The Cn Isc1 P-loop
domain is contained between G113 and A120 and is illustrated
in Fig. 4A. Okamoto et al. have shown that substituting the secondFig. 4. Effect of mutations of the C. neoformans Isc1 P-loop domain on IPC-PLC and
SM-PLC activity. (A) Alignment of amino acid sequences of P-loop-like wild-type
domain and mutant constructs. Amino acids sequences are given for residues 113–
120 of Cn Isc1. The residue(s) mutated from the wild-type is underlined. (B) Effect of
mutations in the P-loop on Isc1 activity. Isc1 activity was measured using SM (SM-
PLC) or IPC (IPC-PLC) as a substrate, as described. Inset in B shows a representative
Western blot of P-loop-like domain mutants of Cn Isc1 with anti-Xpress antibody.
Shown are two different clones (Cn D114A) and Cn F115W) of each over expressed
cells compared to Cn Isc1 wild-type.glycine of the P-loop with an alanine decreased Sc Isc1 activity
against SM nearly 100-fold, though activity against IPC was not as-
sayed [20]. Of interest, Cn has a lysine instead of a glycine at this
position and additional differences between the two Isc1 homolog
exist (Fig. 4A). Thus, we wondered whether the differences in ami-
no acid residues found in the Cn Isc1 are responsible for the lack of
SM-PLC activity. We expressed Cn Isc1 in S. cerevisiae Disc1 and as-
sessed the role of the P-loop residues on both SM-PLC and IPC-PLC
activities. The inset in Fig. 4B is representative Western blot of the
expressed proteins showing that the level of expression was found
to be comparable. We found that D114A and K119A mutations lost
IPC-PLC activity completely Fig. 4B, suggesting that these two ami-
no acids are essential for catalysis of Cn Isc1. In contrast to Sc, nei-
ther of the remaining mutated forms lost IPC-PLC activity nor they
did restore SM-PLC activity, even when the Cn Isc1 P-loop was
identical to the Sc Isc1 P-loop (Fig. 4B) [20]. These results suggest
that either the P-loop is not involved in the substrate recognition
or that it is not sufﬁcient to discriminate between IPC and SM.
We therefore performed docking studies of Cn Isc1 protein in
the attempt to identify key residues that would interact with IPC
and not with SM based on the available structure of B. cereus SMase
[22] and found none. Amino acids predicted to interact with the
choline phosphate of SM, such as D195, N197, W232, D295,
W284 and F285, are either conserved in Cn Isc1 or absent in other
eukaryotic SMase. Thus, which amino acid(s) are most likely to be
responsible for substrate (IPC or SM) recognition or exclusion by Cn
Isc1 is still unknown.
The observation that Cn Isc1 is not able to breakdown host SM
as other microbes do is intriguing. It is possible that, since SM is an
essential sphingolipid for mammalian cell viability [23,24], oppor-
tunistic pathogenic yeasts, such as Cn, may have lost SM-PLC activ-
ity to prevent mammalian cell death due to their close interaction
with their host. This hypothesis is supported by the observation
that Ca, an opportunistic and commensal fungal pathogen, also
does not display SM-PLC activity. In non-opportunistic pathogens,
such as L. major, the ability to breakdown host SM is maintained by
their Isc1 homolog ISCL and, importantly, the authors elegantly
showed that this activity is required for virulence [16].
3.3. Isc1 regulates the level of complex sphingolipids and speciﬁc
phytoceramide species
Since Isc1 generates phytoceramide during the hydrolysis of
complex sphingolipids, we next investigated how the loss of Isc1
modulated the level of complex sphingolipids and phytoceramide.
Complex sphingolipids were measured by pulse chase labeling
using [3H]-inositol because mass spectrometry analysis could not
be performed due the lack of IPC, MIPC and M(IP)2C standards.
Cn Disc1 cells showed a signiﬁcantly increased of IPC C/D and
M(IP)2C compared to Cn WT or Disc1REC strains when cells were
grown at either pH 4.0 (Fig. 5) or 7.0 (data not shown). Similar re-
sults were obtained when cultures were labeled with tritiated
dihydrosphingosine.
Interestingly, deletion of Isc1 causes the accumulation of two
complex sphingolipids more polar than M(IP)2C. In other fungi,
such as Ca, a new inositol containing sphingolipid, dimmannose
inositol phosphorylceramide (M2IPC), has been identiﬁed [25]. In
contrast to IPC, MIPC and M(IP)2C that are anchored to the plasma
membrane, M2IPC can ‘‘diffuse’’ from the plasma membrane to the
cell wall. In the dimorphic fungus Histoplasma capsulatum, in addi-
tion to M2IPC another sphingolipid has been identiﬁed as galacto-
syldimmannose inositolphosphorylceramide (GalM2IPC) which
exists in two forms depending on the addition of a galactofuranose
residue at the 6-position of mannose (yeast form speciﬁc) or the
addition of galactopyranose residue at the 4-position of mannose
(hyphal form speciﬁc) [26,27]. Although not described thus far,
Fig. 5. In vivo labeling of WT, Disc1, and Disc1REC strains of C. neoformans. Cultures
were labeled with 3H-inositol for 30 min, and lipids were extracted and resolved in
a TLC (A) as described in Section 2. Panel A is a representative of three separate
experiments. (B) Quantitative analysis of scraped lipids from the TLC normalized to
phosphorus (Pi) content. P < 0.05, Disc1 versus WT or Disc1REC. Data are aver-
age ± standard deviation of three separate experiments.
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ent in C. neoformans, and, since they are more polar than M(IP)2C,
they would run below M(IP)2C on a TLC plate. Presumably,
M2IPC and GalM2IPC are breakdown by Isc1 and, thus, they would
accumulate in condition in which Isc1 is deleted. Further studies
are clearly needed to investigate such hypotheses.
When we measured the level of phytoceramide using mass
spectrometry, we found that, except at 12 h of growth, at pH 7.0
the WT or Disc1REC strain contained approximately the same level
of total phytoceramide than Disc1 mutant (Fig. 6A) but not at pH
4.0, in which the level of phytoceramide at 12 and 24 h of growth
is signiﬁcantly lower (Fig. 6B). Interestingly, the Disc1 strain grown
at pH 7.0 recovered its total phytoceramide pools very quickly and
by 24 h its level is similar to the one measured in the WT orFig. 6. Isc1 regulates phytoceramide levels in C. neoformans. Mass spectrometry qu
phytoceramide (C and D) of WT,Disc1, and Disc1REC grown at pH 7.0 (A and C) or pH 4.0 (B
Disc1REC at pH 4; #P < 0.05, WT at pH 4.0 versus pH 7.0. Data are average ± standard devDisc1REC strain. In contrast, the Isc1 mutant grown at pH 4.0 does
recover its phytoceramide pool to a level similar to the WT strains
at 48 h of growth.
An advantage of mass spectrometry analysis is the ability to
quantify the different species of lipids. Using this method, we
found that the level of C26 phytoceramide in WT or Disc1REC strain
is signiﬁcantly higher when the strains are grown at low compared
to neutral pH (Fig. 6C and D). Importantly, the Disc1 strain dis-
played a signiﬁcantly lower level of C26 phytoceramide compared
to WT and Disc1REC strains, especially at low pH (Fig. 5D). This sug-
gests that Isc1 may directly regulate the level of C26 phytocera-
mide in Cn. The lack of C26-phytoceramide in the Disc1 mutant
is intriguing, as it suggests a possible involvement of the plasma
membrane ATPase (Pma1), a proton-extruding plasma membrane
pump, in the regulation of Cn growth when cells are exposed to
low pH [28], which has also been proposed in Sc [29–31].
Although the involvement of sphingolipids in the fungal stress
response appears to be conserved, our study adds a new dimension
because Cn is a facultative intracellular pathogen. Clinically treat-
ing cryptococcal infections is often hampered by the persistence
of fungal cells in infected organs. Similar toMycobacterium tubercu-
losis, cryptococcal persistence may be a result of its intracellular
ability to survive within macrophages [3]. This hypothesis is sup-
ported by studies suggesting that Cn may lay dormant in the lungs
of individuals many years before disease occurs [32,33], and by
studies in M. tuberculosis that, peculiarly, accumulates C26 triacyl-
glycerides during hypoxia, an in vitro condition that mimics the
in vivo dormancy prior re-activation [34]. Thus, through the pro-
duction of C26-phytoceramide, Cn may be protected against acidic
stresses so that it can survive within the hostile phagolysosome of
macrophages.
In conclusion, we show that Cn Isc1 is biochemically different
than Sc Isc1 and it synthesizes mainly C26 phytoceramide espe-
cially in acidic environments. Since the intracellular niche of host
cells in which Cn grows is characteristically acidic, these resultsantiﬁcation of total phytoceramide pools (A and B) and very long chain (C26)
and D). ⁄P < 0.05, Disc1 versus WT or Disc1REC at pH 7; P < 0.05,Disc1 versus WT or
iation of three separate experiments.
640 J. Henry et al. / FEBS Letters 585 (2011) 635–640may have important implications for the interaction of Cn with the
host.
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